Published in Atherosclerosis on May 12, 2010
Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum (2012) 1.34
Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nat Rev Rheumatol (2012) 1.23
Rheumatoid arthritis and cardiovascular disease. Am Heart J (2013) 1.14
Foot health education for people with rheumatoid arthritis: the practitioner's perspective. J Foot Ankle Res (2012) 0.89
Serum levels of asymmetric dimethylarginine and apelin as potential markers of vascular endothelial dysfunction in early rheumatoid arthritis. Mediators Inflamm (2012) 0.84
Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors. Clin Rheumatol (2015) 0.78
Effect of mesenchymal precursor cells on the systemic inflammatory response and endothelial dysfunction in an ovine model of collagen-induced arthritis. PLoS One (2015) 0.77
Relationship of osteoprotegerin to pulse wave velocity and carotid intima-media thickness in rheumatoid arthritis patients. Z Rheumatol (2016) 0.77
Occurrence and effect of lower extremity ulcer in rheumatoid arthritis -- a population-based Study. J Rheumatol (2014) 0.76
A survey of people with foot problems related to rheumatoid arthritis and their educational needs. J Foot Ankle Res (2017) 0.75
Increased carotid intima-media thickness in rheumatoid arthritis: an update meta-analysis. Clin Rheumatol (2015) 0.75
Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des (2011) 4.16
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis. Rheumatology (Oxford) (2012) 3.56
Biomedical journal editing: elements of success. Croat Med J (2011) 3.06
Bilateral ocular myositis as a late complication of dermatomyositis. J Rheumatol (2005) 2.69
Intravitreal administration of the anti-tumor necrosis factor agent infliximab for neovascular age-related macular degeneration. Am J Ophthalmol (2009) 2.55
Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. J Rheumatol (2005) 2.28
Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion. J Clin Endocrinol Metab (2014) 2.07
Diversity, value and limitations of the journal impact factor and alternative metrics. Rheumatol Int (2011) 2.05
Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness. Hypertension (2005) 1.89
The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology (2003) 1.72
Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients. Semin Arthritis Rheum (2010) 1.59
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int (2011) 1.59
Best peer reviewers and the quality of peer review in biomedical journals. Croat Med J (2012) 1.54
Physiological right ventricular adaptation in elite athletes of African and Afro-Caribbean origin. Circulation (2013) 1.53
The relative impact of different measures of adiposity on markers of early atherosclerosis. Int J Cardiol (2006) 1.52
Authorship problems in scholarly journals: considerations for authors, peer reviewers and editors. Rheumatol Int (2012) 1.52
Left-ventricular hypertrophy is associated better with 24-h aortic pressure than 24-h brachial pressure in hypertensive patients: the SAFAR study. J Hypertens (2014) 1.51
Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells. Clin Immunol (2008) 1.49
Association between 24-h blood pressure monitoring variables and brain oedema in patients with hyperacute stroke. J Hypertens (2003) 1.47
Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis (2007) 1.46
Self-correction in biomedical publications and the scientific impact. Croat Med J (2014) 1.44
Genetic variations of the endothelial nitric oxide synthase gene are related to increased levels of C-reactive protein and macrophage-colony stimulating-factor in patients with coronary artery disease. Thromb Haemost (2006) 1.44
Mycophenolate versus cyclophosphamide for progressive interstitial lung disease associated with systemic sclerosis: a 2-year case control study. Lung (2013) 1.43
Heartscore calculated in individuals younger than 40 years is related to vascular markers of early atherosclerosis. Eur J Cardiovasc Prev Rehabil (2008) 1.41
Conflicts of interest in biomedical publications: considerations for authors, peer reviewers, and editors. Croat Med J (2013) 1.40
The Keith-Wagener-Barker and Mitchell-Wong grading systems for hypertensive retinopathy: association with target organ damage in individuals below 55 years. J Hypertens (2015) 1.40
Pressure wave reflections, central blood pressure, and aortic stiffness in patients with Adamantiades-Behcet's disease: a cross-sectional case-control study underlining the role of chronic corticosteroid treatment. Am J Hypertens (2006) 1.39
Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study. Arthritis Res Ther (2009) 1.39
Twenty-four-hour heart rate and blood pressure are additive markers of left ventricular mass in hypertensive subjects. Am J Hypertens (2006) 1.38
Open access: changing global science publishing. Croat Med J (2013) 1.38
Obesity in rheumatoid arthritis. Rheumatology (Oxford) (2010) 1.32
Upgrading instructions for authors of scholarly journals. Croat Med J (2014) 1.31
Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study. Arterioscler Thromb Vasc Biol (2009) 1.30
Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis. Eur J Cardiovasc Prev Rehabil (2009) 1.30
Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-α therapy. Rheumatol Int (2010) 1.28
Long-term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation. Am J Cardiol (2006) 1.28
Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review. J Am Acad Dermatol (2009) 1.27
Promoting transparent and accurate reporting of research studies in rheumatology: endorsement of reporting guidelines in rheumatology journals. Semin Arthritis Rheum (2013) 1.23
Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? Ann Rheum Dis (2009) 1.22
The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal. Semin Arthritis Rheum (2009) 1.22
The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J (2010) 1.21
Well-being in rheumatoid arthritis: the effects of disease duration and psychosocial factors. J Health Psychol (2005) 1.20
Infliximab for chronic cystoid macular edema associated with uveitis. Am J Ophthalmol (2004) 1.19
Association of interleukin-6 (IL-6)-174G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking. Atherosclerosis (2008) 1.19
Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation. Retina (2007) 1.19
Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis. Clin Immunol (2008) 1.17
Vascular function and morphology in rheumatoid arthritis: a systematic review. Rheumatology (Oxford) (2011) 1.16
Regression of neovascular age-related macular degeneration following infliximab therapy. Am J Ophthalmol (2005) 1.15
The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis. BMC Musculoskelet Disord (2010) 1.15
Aberrant reactive oxygen and nitrogen species generation in rheumatoid arthritis (RA): causes and consequences for immune function, cell survival, and therapeutic intervention. Antioxid Redox Signal (2010) 1.13
Inflammation and atherosclerosis in rheumatoid arthritis. Expert Rev Mol Med (2005) 1.13
Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int (2011) 1.12
Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther (2008) 1.11
Multidisciplinary bibliographic databases. J Korean Med Sci (2013) 1.11
Inverted BMI rather than BMI is a better proxy for percentage of body fat. Ann Hum Biol (2011) 1.11
Rheumatoid cachexia and cardiovascular disease. Nat Rev Rheumatol (2010) 1.11
The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol (2010) 1.10
Impact of obesity in intima media thickness of carotid arteries. Obesity (Silver Spring) (2006) 1.10
Central blood pressures: do we need them in the management of cardiovascular disease? Is it a feasible therapeutic target? J Hypertens (2007) 1.09
Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis. Arthritis Res Ther (2012) 1.09
Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis. Clin Rheumatol (2008) 1.08
Lupus headache may not exist: comment on the article by Hanly et Al. Arthritis Rheumatol (2014) 1.06
The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin. Eur Heart J (2011) 1.05
Psychological well-being across 1 year with rheumatoid arthritis: coping resources as buffers of perceived stress. Br J Health Psychol (2007) 1.05
Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther (2006) 1.03
Individualised aerobic and resistance exercise training improves cardiorespiratory fitness and reduces cardiovascular risk in patients with rheumatoid arthritis. Ann Rheum Dis (2012) 1.01
A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain (2004) 1.00
Intravitreal infliximab for sight-threatening relapsing uveitis in Behçet disease: a pilot study in 15 patients. Am J Ophthalmol (2012) 1.00
Acute effects of caffeine on blood pressure and wave reflections in healthy subjects: should we consider monitoring central blood pressure? Int J Cardiol (2005) 1.00
Sleep disturbances and interleukin 6 receptor inhibition in rheumatoid arthritis. J Rheumatol (2011) 1.00
Type 2 diabetes mellitus is associated with obesity, smoking and low socioeconomic status in large and representative samples of rural, urban, and suburban adult Greek populations. Hormones (Athens) (2013) 1.00
Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis. Endothelium (2008) 0.99
The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study. Arthritis Res Ther (2012) 0.99
Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors. Curr Vasc Pharmacol (2010) 0.99
Inflammation, carotid intima-media thickness and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther (2008) 0.99
Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors. Hypertension (2009) 0.99
Common carotid artery intima-media thickness in patients with brain infarction and intracerebral haemorrhage. Cerebrovasc Dis (2004) 0.97
The impact of inflammation on metabolomic profiles in patients with arthritis. Arthritis Rheum (2013) 0.97
The association between microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther (2011) 0.96
Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations. J Neurol (2013) 0.96
Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis. Clin Exp Rheumatol (2011) 0.95
Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis. Ann Rheum Dis (2011) 0.95